$HNGE

Insight Holdings Group, LLC sold $51.6M of HNGE (indirect holdings)

Insight Holdings Group, LLC sold 727,793 indirectly-held shares of Hinge Health, Inc. (HNGE) at an average of $70.95 ($70.21–$71.67, $51.63M total) across 18 trades over 2026-06-22 to 2026-06-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Insight Holdings Group, LLC
Published Jun 25, 2026, 1:56 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 25, 2026, 2:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HNGE
Neutral
medium confidence
Mentioned
$HNGE
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

The newest actionable element is the disclosed sale size (~$51.6M) and the fact it fully reduced holdings to 0 shares after the transaction window.

02

Market read

Traders may reassess short-term sentiment around HNGE due to a large insider sale, but the 10b5-1 structure limits inference about new negative fundamentals.

03

What to watch

The filing is indirect (ownership form: indirect) and does not reveal the economic rationale; traders should avoid extrapolating fundamentals from a scheduled sale alone.

Relevance 7/10Novelty 6/10Timing: after-hours/filing timestamp (filed 2026-06-24) for trades dated 2026-06-22 to 2026-06-24

Background

This is an SEC Form 4 insider transaction: Insight Holdings Group, LLC (10% owner) sold Hinge Health shares via open-market trades under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$HNGENeutralMedium confidence
Context

Hinge Health (HNGE) disclosed an SEC Form 4 showing Insight Holdings Group sold 727,793 shares in open-market trades for ~$51.6M.

Expected impact

Near-term impact likely limited; any reaction would be sentiment-driven around insider selling rather than new company fundamentals.

Evidence & confidence

The filing is primary-source and sizable, but it explicitly states a pre-arranged Rule 10b5-1 plan and provides no new operating/regulatory/financial catalyst.

Market effects

Could modestly affect sentiment for digital health/orthopedics-adjacent names if insider selling is interpreted as risk-off, but no sector-wide datapoint is provided.

No direct regional market linkage beyond US-listed HNGE sentiment.

No global macro or cross-border transaction details; impact confined to HNGE positioning.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect liquidity/portfolio rebalancing rather than bearish expectations.

Key entities

  • Hinge Health, Inc.

    US-listed company (HNGE) whose shares were sold in the reported insider transaction.

  • Insight Holdings Group, LLC

    10% owner reporting an indirect open-market sale of HNGE shares under a pre-arranged 10b5-1 plan.

Related articles

$HNGEHighAI 9/10

Why is Hinge Health stock surging today?

Hinge Health (HNGE) shares rose 11.6% after the company reported Q2 2026 revenue of $212.8M (+53% YoY) and non-GAAP diluted EPS of $0.59 vs $0.13 consensus. Free cash flow exceeded $100M. Hinge raised FY2026 revenue guidance to $818M-$824M and Q3 guidance to $223M-$225M, and agreed to buy Cylinder Health for $105M cash. Analysts lifted price targets.

$HNGELowAI 8/10

Jim Cramer Says Hinge Health “Delivered a True Blowout Set of Numbers”

On Jim Cramer’s “Mad Money,” he discussed Hinge Health (NYSE:HNGE) after the company reported strong results. Cramer said revenue rose 47% year over year, margins beat expectations, and earnings topped estimates. He noted management raised current-quarter guidance and substantially lifted the full-year forecast, and the stock jumped about 10% in one session, then traded sideways.